在帕金森病中对眼睛对齐和差异驱动的变的客观评估
Palak Gupta1,2,3, Jordan M Murray2, Sinem Balta Beylergil3
1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Frontiers in aging neuroscience
|November 29, 2023
概括
帕金森病 (PD) 患者经常经历双眼视,原因是眼睛对齐控制受损和缩缺陷. 这些视力问题,包括眼睛偏差和融合问题,即使运动症状轻微,也很常见.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 运动障碍 运动障碍
背景情况:
- 双眼视 (双眼视) 影响了高达三分之一的帕金森病患者.
- 了解PD中双眼眼背后的机制对于患者护理至关重要.
研究的目的:
- 为了研究帕金森病中双眼视的机械基础.
- 为了确定基于时间的眼睛对齐控制,眼睛偏差和因差异驱动的融合缺陷之间的关系.
主要方法:
- 高分辨率视频眼镜被用于评估33名PD患者和10名健康对照者的眼睛对齐和变.
- 测量包括眼睛的偏差,基于时间的眼睛对齐控制,眼的运动,以及的启动和维护.
主要成果:
- 与对照人群相比,帕金森病患者在单眼观看下表现出较大的眼睛偏差,以及与对照人群相比,联开始和维持的缺陷.
- 眼睛对齐控制较差的PD受试者表现出更显著的合缺陷和更高的失败合启动的可能性.
- 运动症状的严重程度 (UPDRS得分) 和观察到的变缺陷之间没有发现显著的相关性.
结论:
- 该队列中的大多数PD患者呈现双眼功能障碍,其特征是眼睛偏差增加和因差异驱动的接缺陷.
- 双眼观察下眼睛偏差的控制受损与更明显的融合启动和融合维护接缺陷有关.
- 对帕金森病患者的双眼视觉评估很重要,不管他们的运动症状的严重程度如何.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


